+44 (0) 20 7549 9987 | USA callers: 00-1-718-682-4567

Contact Us Now

Vsisiongain report says ‘3D Printing For Healthcare Market Set To Grow To $4.7bn By 2023’

30 July 2018
Pharma

Visiongain’ has launched a new pharma report 3D Printing for Healthcare World Market Report: Forecasts by Products (Dental Products, Medical Implants, Bio-Printing, Others) By Technology (Hardware, Software, Services) & Analysis of Opportunities in Personalised Medicine, Medical Devices, Tailor Made Prosthetics, Orthopaedic Implants & Drugs

The 3D printing for healthcare market is in an emerging state due to the large number of developments by the leading market players and high adoption rate of 3D printing for healthcare. The key players of the world 3D printing for healthcare market are employing novel concepts and ideas, improving manufacturing techniques, and improving the current set of products, besides enhancing their profitability to gain a competitive edge over other market players. Therefore, key players have adopted acquisition & product launch and development as the key developmental strategies to cater to the changing demands of end users.

The lead analyst of the report commented “The demand for 3D printed products and solutions in healthcare will increase throughout the forecast period. The ability to create patient-specific solutions across a variety of healthcare applications offers a number of advantages in terms of both costs and outcomes for patients, payers and providers. Therefore, implementation of 3D printing technology is being driven by healthcare providers who aim to improve quality of life for their patients whilst minimising costs, and by patients, whose improving knowledge and understanding of their treatment options ensures they demand a more personalised approach.”

Leading companies featured in the report include 3D Systems Inc., Arcam AB, Autodesk Inc., ExOne Company, H Intressenter AB, Optomec, Inc., Organovo Holdings, Inc., Ponoko Limited, Stratasys Ltd, Voxeljet AG

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 208 781 6953

About Visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports cusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Pharma Wholesale and Distribution Market Report 2022-2032

The pharma wholesale and distribution market was valued at US$511.80 billion in 2021 and is projected to grow at a CAGR of 7.84% during the forecast period 2022-2032.

29 September 2022

Read

Visiongain Publishes Mesenchymal Stem Cells Market Report 2022-2032

The mesenchymal stem cells market was valued at US$2.44 billion in 2021 and is projected to grow at a CAGR of 13.82% during the forecast period 2022-2032.

21 September 2022

Read

Visiongain Publishes Advanced Wound Care Management Market Report 2022-2032

The global advanced wound care management market is estimated to be valued at US$12,581.3 million in 2022. The market is projected to reach a market value of US$23,307.5 million by 2032 and is projected to grow at a CAGR of 6.36% during the forecast period 2022-2032.

16 September 2022

Read

Visiongain Publishes Gene Therapy R&D Market Report 2022-2032

The gene therapy R&D market was valued at US$1,653.0 million in 2021 and is projected to grow at a CAGR of 30.1% during the forecast period 2022-2032.

15 September 2022

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever